Becton Dickinson & Co.
185 recalls on record · Latest: May 6, 2026
Subscribe to new Becton Dickinson & Co. recalls (RSS)
Agency notice ledger
Federal filing book Becton Dickinson & Co. HEAVY-BOOK · SINGLE-AGENCY
#83 of 14,151 · 185 notices · 0.177% archive
- BOOK 185 notices
- RANK #83 of 14,151
- SHARE 0.177% archive
- AGENCY FDA Devices (185)
- CAT medical devices
- CATS 1 category
- LATEST May 6, 2026
- PHOTO Chevrolet
Nearest notice-volume peer: Chevrolet (2 notice gap)
Becton Dickinson & Co. accounts for about 0.177% of the 104,423-notice archive on 185 distinct filings — a heavy share signal beside absolute volume. FDA · CPSC · USDA FSIS · NHTSA notice stamps for this firm. Read with this firm → · Dominant category → · Similar-volume firm →
Becton Dickinson & Co.'s standing among 14,151 recalling firms
Becton Dickinson & Co. ranks 83rd of 14,151 tracked firms by distinct recall-event count. Archive size reflects filing volume, not inherent product danger.
Becton Dickinson & Co. vs all firms by recall-notice count
Where this firm's archive sits among every tracked recalling manufacturer
185 83rd of 14151 higher than 14,068 of 14,151 firms
Firms, banded by distinct federal recall-event inventory
Each bar is a band; taller bars hold more firms. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source FDA · CPSC · USDA FSIS · NHTSA federal recall filings · 2026-09-13
Becton Dickinson & Co. in the notice-volume neighbourhood
Distinct federal recall events among this firm and nearest nationwide peers
- High Liner Fo…
High Liner Foods Inc.
191 notices
- American Cont…
American Contract Systems Inc
190 notices
- Chevrolet,Gmc
Chevrolet,Gmc
188 notices
- Becton Dickin… (this)
Becton Dickinson & Co.
185 notices
- Chevrolet
Chevrolet
183 notices
- Becton Dickin…
Becton Dickinson & Company
179 notices
What this shows Becton Dickinson & Co. holds about 0.177% of archive notices alongside 185 distinct filings.
FDA Devices Moderate Feb 14, 2024
BD BBL Sensi Disc Ertapenem- 10 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 232174 and 232175¿
FDA Devices Moderate Feb 14, 2024
BD BBL Sensi Disc Ciprofloxacin- 5 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231657¿and 231658¿
FDA Devices Moderate Feb 14, 2024
BD BBL Sensi Disc Aztreonam - 30 ug¿, used for semi-quantitative in vitro susceptibility testing. Catalog Numbers 231640¿and 231641.
FDA Devices Moderate Feb 14, 2024
BD BBL Sensi Disc Levofloxacin- 5 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231705 and 231706¿
FDA Devices Moderate Feb 14, 2024
BD BBL Sensi Disc Augmentin - 3¿g, Catalog Number 291270¿used for semi-quantitative in vitro susceptibility testing.
FDA Devices Moderate Feb 14, 2024
BD BBL Sensi Disc Sulfamethoxazole with Trimethoprim 23.75/1.25 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231536 and 231539¿
FDA Devices Moderate Feb 14, 2024
BD BBL Sensi Disc Ceftazidime- 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231632¿and 231633¿
FDA Devices Moderate Feb 14, 2024
BD BBL Sensi Disc Ofloxacin- 5 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231672¿
FDA Devices Moderate Feb 14, 2024
BD BBL Sensi Disc Cefixime - 5 ug¿, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231664¿
FDA Devices Moderate Feb 14, 2024
BD BBL Sensi Disc Ampicillin - 10 ¿g, Catalog No. 230705 and 231264; 2 ¿g, Catalog No. 231263. Used for semi-quantitative in vitro susceptibility testing.
FDA Devices Moderate Feb 14, 2024
BD BBL Sensi Disc Cefuroxime- 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231621¿
FDA Devices Moderate Feb 14, 2024
BD BBL Sensi Disc Ceftriaxone- 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231634 and 231635¿
FDA Devices Moderate Feb 14, 2024
BD BBL Sensi Disc Doripenem- 15 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 232219¿
FDA Devices Moderate Feb 14, 2024
BD BBL Sensi Disc Ampicillin with Sulbactam 10/10 ¿g, Catalog Number 231660. Used for semi-quantitative in vitro susceptibility testing.
FDA Devices Moderate Feb 14, 2024
BD BBL Sensi Disc Clarithromycin- 15 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231678¿
FDA Devices Moderate Oct 18, 2023
BD BACTEC Plus Aerobic/F Culture Vials, Catalog Number 442023
FDA Devices Moderate Jul 12, 2023
BD Synapsys Informatics Solution, Catalog Number 444150
FDA Devices Moderate Jun 14, 2023
BD Veritor System for Rapid Detection of SARS-CoV-2 & Flu A+B, 30 Single Use Test Devices- Intended for the in vitro, simultaneous qualitative detection and differentiation of SARS-CoV-2 nucleocapsid antigen and influenza A and/or B Catalog Number: 256088
FDA Devices Moderate Apr 26, 2023
BD Kiestra InoqulA+ with BD Kiestra" InoqulA+" and BeA Software version 5.1 and 5.1.1 as part of the Icefall A platform. An in vitro diagnostic medical device intended to automate specimen processing according to user-defined procedures and protocols. Catalog (Ref) No. : 447213
FDA Devices Moderate Dec 21, 2022
BBL Chocolate II Agar- IVD for the isolation and cultivation of Neisseria species. Catalog (Ref) Number: 221267
FDA Devices Moderate Nov 23, 2022
BD Phoenix PMIC/ID-107: The Phoenix PMIC/ID panel is used for the rapid identification and susceptibility of most aerobic and facultative anaerobic gram-positive bacteria of human origin with selected antimicrobial agents when used with the BD Phoenix Automated Microbiology System. Catalog (Ref) Number: 448607
FDA Devices Moderate May 11, 2022
BD Synapsys Microbiology Informatics Solution, Catalog Number 444150, Software Version 4.10
FDA Devices Moderate Feb 16, 2022
BD Veritor Plus Analyzer - intended to provide rapid test results in near-patient settings. Catalog Number: 256066
FDA Devices Moderate Apr 21, 2021
BioGX SARS-CoV-2 Reagents for BD MAX System-IVD PCR test intended for the qualitative detection of nucleic acid from the SARS-CoV-2 in nasopharyngeal specimens Catalog Number: 444213
FDA Devices Moderate Apr 14, 2021
BD BBL Martin-Lewis Agar, 100 Ea - Product Usage: used for the isolation of pathogenic Neisseria from specimens containing mixed flora of bacteria and fungi. Catalog Number: 221558
FDA Devices Moderate Apr 14, 2021
BD BBL Martin-Lewis Agar 20 Ea - Product Usage: use for the isolation of pathogenic Neisseria from specimens containing mixed flora of bacteria and fungi. Catalog Number: 221557
FDA Devices Moderate Feb 17, 2021
BioGX SARS-CoV-2 Reagents for BD MAX System Catalog number (REF) 444213. In vitro diagnostic. SARS-CoV-2 Reagents is a real-time RT-PCR test intended for the qualitative detection of nucleic acid from the SARS-CoV-2 in nasopharyngeal, nasal, mid-turbinate, and oropharyngeal swab specimens, nasopharyngeal wash/aspirate or nasal aspirates obtained from individuals suspected of COVID-19 by their healthcare provider.
FDA Devices Moderate Jan 6, 2021
BD Phoenix PMIC-107: IVD is intended for the in vitro rapid identification (ID) of gram-positive bacteria from pure culture belonging to the genera Staphylococcus, Enterococcus, and other gram-positive cocci and gram-positive bacilli Catalog Number: 448417
FDA Devices Moderate Jan 6, 2021
BD Phoenix PMIC/ID-108: IVD is intended for the in vitro rapid identification (ID) of gram-positive bacteria from pure culture belonging to the genera Staphylococcus, Enterococcus, and other gram-positive cocci and gram-positive bacilli Catalog Number: 448608
FDA Devices Moderate Jan 6, 2021
BD Phoenix PMIC-108: IVD is intended for the in vitro rapid identification (ID) of gram-positive bacteria from pure culture belonging to the genera Staphylococcus, Enterococcus, and other gram-positive cocci and gram-positive bacilli Catalog Number: 448418
FDA Devices Moderate Jan 6, 2021
BD Phoenix" PMIC-109: IVD is intended for the in vitro rapid identification (ID) of gram-positive bacteria from pure culture belonging to the genera Staphylococcus, Enterococcus, and other gram-positive cocci and gram-positive bacilli Catalog Number: 448419
FDA Devices Moderate Jan 6, 2021
BD Phoenix PMIC/ID-105: IVD is intended for the in vitro rapid identification (ID) of gram-positive bacteria from pure culture belonging to the genera Staphylococcus, Enterococcus, and other gram-positive cocci and gram-positive bacilli Catalog Number: 448605 (Discontinued)
FDA Devices Moderate Jan 6, 2021
BD Phoenix PMIC/ID-109: IVD is intended for the in vitro rapid identification (ID) of gram-positive bacteria from pure culture belonging to the genera Staphylococcus, Enterococcus, and other gram-positive cocci and gram-positive bacilli Catalog Number: 448609
FDA Devices Moderate Jan 6, 2021
BD Phoenix PMIC/ID-107: IVD is intended for the in vitro rapid identification (ID) of gram-positive bacteria from pure culture belonging to the genera Staphylococcus, Enterococcus, and other gram-positive cocci and gram-positive bacilli Catalog Number: 448607
FDA Devices Moderate Jan 6, 2021
BD Phoenix PMIC-110: IVD is intended for the in vitro rapid identification (ID) of gram-positive bacteria from pure culture belonging to the genera Staphylococcus, Enterococcus, and other gram-positive cocci and gram-positive bacilli Catalog Number: 449036:
FDA Devices Moderate Aug 12, 2020
BD MAX SARS-CoV-2 Reagents, Cat. No. 445003 (UDI 00382904450038) and 445003-01 (UDI (01)603829044500301) - Product Usage: intended for the qualitative detection of nucleic acid from the SARS-CoV-2 in nasopharyngeal, nasal, mid-turbinate, and oropharyngeal swab specimens, nasopharyngeal wash/aspirate or nasal aspirates obtained from individuals suspected of COVID-19 by their healthcare provider.
FDA Devices Moderate May 27, 2020
BD BBLTM Gram Crystal Violet 250mL-- IVD Primary stain for Staining Microorganisms, Catalog Number: 212525 - Product Usage: Gram Stain Kits and Reagents are used to stain microorganisms from cultures or specimens by the differential Gram method.
FDA Devices Moderate May 27, 2020
BD BBLTM Gram Crystal Violet 3.8L-- IVD Primary stain for Staining Microorganisms, Catalog Number: 212526 - Product Usage: Gram Stain Kits and Reagents are used to stain microorganisms from cultures or specimens by the differential Gram method.
FDA Devices Moderate May 27, 2020
BD BBLTM Gram Stain Kit with Stabilized Iodine-- IVD For the differential staining of bacteria, Catalog Number: 212539 - Product Usage: Gram Stain Kits and Reagents are used to stain microorganisms from cultures or specimens by the differential Gram method.
FDA Devices Moderate Sep 11, 2019
BD Kiestra InoqulA+ Software Version 20.3. IVD automated specimen processing Catalog Number : 447213
FDA Devices Moderate Sep 11, 2019
BD Kiestra InoqulA Software Version 20.3.IVD automated specimen processing Catalog Number: 447202
FDA Devices Moderate Aug 28, 2019
Kit BD Max Enteric Viral Panel RUO; Catalog # 443715
FDA Devices Moderate Aug 28, 2019
Kit BD Max StaphSR; Catalog # 443418
FDA Devices Moderate Aug 28, 2019
Kit BD Max ExK DNA 1 USA; Catalog # 442817
FDA Devices Moderate Aug 28, 2019
Kit EXT Enteric Bacterial Panel; Catalog # 443812
FDA Devices Moderate Aug 28, 2019
Kit BD Max Check-Points CPO IVD EU; Catalog # 278102
FDA Devices Moderate Aug 28, 2019
Kit BD Max Enteric Viral Panel EU Catalog # 443985
FDA Devices Moderate Aug 28, 2019
Kit BD Max ExK TNA 2; Catalog # 442825
FDA Devices Moderate Aug 28, 2019
Kit BD Max ExK DNA 1 EU LUO; Catalog # 442818
FDA Devices Moderate Aug 28, 2019
Kit BD Max MRSA; Catalog # 442953
Becton Dickinson & Co. carries an outsized archive share
Drug and device firms outside this manufacturer and state, matched by notice volume and category footprint.
Similar recall count
Nearest multi-notice firms by distinct-event totals (185 here — heavy-book).
Similar medical devices volume
Nearest multi-notice firms in the same narrow category lane.
Frequently Asked Questions
How many federal recall notices name Becton Dickinson & Co.? ▼
PlainRecalls indexes 185 distinct federal recall events naming Becton Dickinson & Co., aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (archive as of September 2026). That count is an issuance inventory, not a hazard score.
Where does Becton Dickinson & Co. sit among other recalling firms? ▼
Becton Dickinson & Co. ranks #83 of 14,151 by distinct recall-event count among 14,151 firms in this archive (99th percentile of firms with fewer notices). Rank tracks filing frequency, not product danger.
Which agency issues most of Becton Dickinson & Co.'s notices? ▼
FDA Devices accounts for 185 of this firm's 185 indexed notices.
What product category dominates Becton Dickinson & Co.'s filing book? ▼
Filings for Becton Dickinson & Co. span 1 product category, led by medical devices. Browse that category archive for peer firms and related notices.
Is a higher notice count more dangerous? ▼
No. Archive size reflects how often federal agencies publish recalls naming the firm — reporting volume, coverage, and product range all move the number. Always verify the individual notice with the issuing agency before acting on a specific product.
Becton Dickinson & Co.: 185 federal recall notices aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (lead agency FDA Devices). Verify individual notices with FDA directly before acting on a specific recall.
Firm-level totals aggregate distinct federal recall events naming Becton Dickinson & Co.; individual notices remain authoritative on each linked recall page.
Methodology · Corrections · FDA · CPSC · USDA FSIS · NHTSA · Archive as of September 2026